| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/171.1.198 |
| P698 | PubMed publication ID | 7798664 |
| P50 | author | Karl Albert Brokstad | Q50944771 |
| P2093 | author name string | R Jonsson | |
| J Olofsson | |||
| R J Cox | |||
| L R Haaheim | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | local immune response | Q106596240 |
| P304 | page(s) | 198-203 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Parenteral influenza vaccination induces a rapid systemic and local immune response | |
| P478 | volume | 171 |
| Q30228084 | A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine |
| Q36365672 | Activation of virus replication after vaccination of HIV-1-infected individuals. |
| Q35999563 | Advances in pneumococcal vaccines: advantages for infants and children |
| Q30395583 | An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers |
| Q57714273 | Antibody response to the influenza vaccine in healthcare workers |
| Q30398435 | Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection |
| Q39242282 | Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination |
| Q34675315 | Detecting viruses by using salivary diagnostics |
| Q91627985 | Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children |
| Q35928222 | Exploiting human memory B cell heterogeneity for improved vaccine efficacy |
| Q79175184 | Flu vaccination in patients with acute coronary syndromes: treatment benefit in prespecified subgroups |
| Q90039584 | HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men |
| Q42200908 | Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine. |
| Q37260869 | Human B cell subsets |
| Q59243321 | Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine |
| Q30364187 | Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements |
| Q47937377 | Immune responses after live attenuated influenza vaccination |
| Q37376537 | Immunomodulatory effects of ResistAid™: A randomized, double-blind, placebo-controlled, multidose study |
| Q45744080 | Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine |
| Q30376482 | Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge |
| Q36709727 | Induction of secretory immunity and memory at mucosal surfaces |
| Q30427946 | Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses. |
| Q26783844 | Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines |
| Q36221067 | Influenza and pneumonia in pregnancy |
| Q30385118 | Influenza vaccines: from surveillance through production to protection. |
| Q35629114 | Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines |
| Q37071008 | Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients |
| Q37161924 | Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils |
| Q36252434 | Local and systemic cytokine and chemokine responses after parenteral influenza vaccination |
| Q38636875 | Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation |
| Q51645113 | Lymphocyte distribution in the tonsils prior to and after influenza vaccination. |
| Q30376350 | Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets. |
| Q34004276 | Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents |
| Q35588006 | Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria |
| Q30421413 | Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine |
| Q33975722 | Nosocomial spread of viral disease |
| Q36973944 | Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses |
| Q38639288 | Pilot investigation into the sickness response to influenza vaccination in adults: Effect of depression and anxiety |
| Q35230589 | Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands |
| Q36934373 | Prevention of infectious diseases in athletes |
| Q37279777 | Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial |
| Q42852003 | Quantity, not quality, of antibody response decreased in the elderly |
| Q24644672 | Rapid cloning of high-affinity human monoclonal antibodies against influenza virus |
| Q35130615 | Role of secretory antibodies in the defence against infections |
| Q51667953 | Route of administration is the prime determinant of IgA and IgG2a responses in the respiratory tract of mice to the cold-adapted live attenuated influenza A donor strain A/Leningrad/134/17/57. |
| Q34394519 | Standardization of a method to detect bovine sperm-bound antisperm antibodies by flow cytometry |
| Q74255834 | Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines |
| Q74600748 | Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study |
| Q36256314 | Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015). |
| Q48145472 | The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy. |
| Q43727744 | The effect of zanamivir treatment on the early immune response to influenza vaccination |
| Q35886894 | The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine |
| Q30417273 | The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants. |
| Q79912513 | The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man |
| Q51978164 | The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. |
| Q54259409 | Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008. |
| Q38046109 | Tools to therapeutically harness the human antibody response |
| Q35207950 | Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy |
| Q78383258 | [Secondary prevention of coronary artery disease. Flu vaccinations and new evidence of the role of infection in acute coronary syndromes] |
Search more.